- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
GE Debuts PET/MR
GE Healthcare will debut at RSNA 2014 their SIGNA PET/MR system.
GE Healthcare will showcase at RSNA 2014 the SIGNA PET/MR, which GE calls the world’s first time-of-flight capable, integrated, simultaneous PET/MR system.
The SIGNA PET/MR is powered by simultaneous image acquisition from GE’s latest 3.0 Tesla magnetic resonance (MR) technology, and innovative positron emission tomography (PET) technology and offers clinicians improved scan efficiency that may lead to more effective treatment paths, GE said.
The SIGNA PET/MR features GE’s MR-compatible silicon photomultiplier detector (SiPM) technology, which is categorized by its enhanced sensitivity, GE said. It also features fast coincidence timing resolution, enabling TOF reconstruction, GE said. TOF helps to improve PET image quality with the potential for higher structural detail and signal-to-noise ratio, GE said. The SIGNA PET/MR should be fully upgradable form a Discovery MR750w 3.0T.
The SIGNA PET/MR is 510(k) pending at the FDA.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
